RG 6100Alternative Names: anti-tau monoclonal antibody - AC Immune/Genentech; RG6100
Latest Information Update: 29 Jul 2016
At a glance
- Originator AC Immune
- Developer AC Immune; Genentech
- Class Monoclonal antibodies
- Mechanism of Action Tau protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Alzheimer's disease